Centaurea ainetensis
Centaurea ainetensis · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Centaurea ainetensis is a botanical species that has gained significant scientific interest due to its diverse therapeutic potential. Research focusing on the plant extract derived from its flower has revealed promising antitumor activities. Specifically, the presence of specialized chemical compounds, such as Salograviolide A and Salograviolide B, plays a crucial role in its biological effects. These bioactive constituents are being investigated for their ability to target specific pathological conditions, including colon cancer and colorectal cancer. Consequently, this plant serves as a valuable subject in the ongoing search for novel natural agents against gastrointestinal malignancies.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Asteraceae
- Distribution
- Not available
- Plant Parts
- Flower
Classification
Taxonomy
Centaurea ainetensis is a distinctive species that belongs to the vast kingdom Plantae. Within this botanical realm, it is classified under the class Equisetopsida. The plant is further organized into the order Asterales, showcasing its specific evolutionary lineage. As a member of the genus Centaurea, it shares close ties with many other knapweeds. Ultimately, it finds its place within the diverse and widespread family Asteraceae.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Asterales |
| Family | Asteraceae |
| Genus | Centaurea |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Centaurea ainetensis is a notable plant species primarily found within the Asia-temperate region. Its specific geographical footprint extends across Western Asia, making it a characteristic element of that landscape. Within this territory, the plant maintains a particularly consistent presence throughout the Lebanon-Syria area. Understanding these distribution patterns provides valuable insight into the ecological niche this species occupies. Such data is essential for botanists studying the biodiversity of the Middle Eastern highlands.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Biological Activities
Centaurea ainetensis is a Middle Eastern indigenous plant that contains valuable bioactive compounds. Research has identified the sesquiterpene lactone salograviolide A, isolated from this species, as possessing selective antitumor properties. When studied in the context of human colon cancer cell lines, these plant-derived compounds demonstrate significant potential for inhibiting cell viability. Specifically, the mechanism involves triggering ROS-dependent apoptosis and disrupting the mitochondrial membrane potential to combat cancer cells. These findings suggest that derivatives from Centaurea ainetensis may hold great therapeutic interest for future oncology treatments.
Compounds
Centaurea ainetensis is an indigenous medicinal plant native to the Middle Eastern region that serves as a rich source of bioactive compounds. Specifically, researchers have isolated two significant sesquiterpene lactones from this plant known as Salograviolide A and Salograviolide B. These guaianolide-type molecules have demonstrated impressive biological potential, particularly in the fight against colorectal cancer. Studies show that Salograviolide A also possesses notable anti-inflammatory properties by reducing cytokine levels and inhibiting inflammatory pathways. Consequently, both Salograviolide A and B are being investigated as promising chemical leads for the development of advanced anti-cancer and anti-inflammatory therapies.
Conditions
Centaurea ainetensis exhibits significant therapeutic potential by effectively treating colorectal cancer and colon cancer through its sesquiterpene lactone components. The plant also plays a crucial role in managing inflammatory responses by treating cytokine levels and lowering the overall inflammation score. Furthermore, it works to treat the interleukin-1 (IL-1) induced increase in cyclooxygenase-2 (COX-2) levels in intestinal epithelial cells. These diverse biological activities highlight the plant's efficacy in both oncology and anti-inflammatory applications.
Preparations
Centaurea ainetensis is prepared as a plant extract to investigate its potential anti-inflammatory activities. This specific plant extract was utilized alongside the isolated molecule Salograviolide A in various biochemical assays. Researchers used the extract to test effects on interleukin-1 induced increases in COX-2 levels and NF-kappaB translocation. Furthermore, the plant extract was applied in an iodoacetoamide-induced rat model to study its impact on inflammation scores. These studies demonstrate that the preparation of Centaurea ainetensis as an extract is a key component in evaluating natural therapies for inflammatory diseases.
Parts used
Centaurea ainetensis flowers were identified as one of the most efficacious plant parts during the screening of indigenous Lebanese species for antimicrobial activity. In this study, methanol extracts derived from these specific floral parts demonstrated a high success rate, showing susceptibility against 88.8% of the tested microorganisms. This level of effectiveness highlights the potential medicinal value found within the flower of the plant. The researchers noted that methanol extracts generally outperformed water extracts in terms of antimicrobial potency across the various species tested. Ultimately, these findings underscore the importance of examining specific plant parts, such as the flowers of Centaurea ainetensis, to discover potent natural compounds.